Atlas Trials

Reduction of Exposure, Inflammation, and Oxidative Stress Following at Least 2 Years of Switching to THS Use Compared to Cigarette Smoking

Clinical trial NCT05385055 · COMPLETED

Trial details

NCT number
NCT05385055
Sponsor
Philip Morris Products S.A.
Status
COMPLETED
Study type
OBSERVATIONAL
InflammationOxidative StressSmokingSmoking Abstinence
Start date
2022-06-13
Primary completion
2023-12-27
Enrollment
974

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.